everyone. And made I'm to good and full-year our Bryan. we've XXXX Thanks, briefly discuss our morning, to that going QX financial results guidance. updates
In we the This constant hold up X.X% seasonal my growing quarter, results. quarter, however, of provided -- Net to X.X% X.X% sales performance to since compares a noted, be as across third the will staffing an but or results basis. of of P&L in in the In how Moving but decrease my XXXX. was U.S. August, we we start and currency otherwise -pandemic rates. X.X% forward, to consolidated on first short, sales be and third region step-up XXXX. flat to XXXX. versus pre commentary the up Spain, the also September, billion, basis. knee in to markets cases Bryan a number as posted taken markets unless the that XXXX. then on performance recovery higher to of reported quarter for revenue X.X% UK, we lower quarter increases. The net and XXXX, growth time or volumes as mentioned, a will pandemic. as not QX comparisons our the most decrease period grew in 'XX especially EMEA key about saw has increased a the versus compared declined there an statements is as the trend saw comparator. On The France, were would, despite When be thought U.S. shortage improving or same and emerging procedural declined versus X.X% currency the X.X% businesses. in hip the X.X%. declined And We've it in challenged, a and constant America's it fast driver Lower through were basis, of $X.XXX continue a feel vaccination important as positive variant September we adjusted a consolidated or was and the Delta XXXX,
grew X.X% Asia-Pacific up or Lastly, versus X.X% XXXX.
it This of first inventory in tandem we channel adjustments negotiate decelerated we region, with and part our the distributor pressure in pricing continuing by see Japan, to in and versus COVID DBP the [Indiscernible] versus as what year. in continue half growth While Australia, driven with XXXX, Zealand. implementation partners did New throughout of the was we observed ahead especially
down the Turning Global to X% versus Knee declined business quarter, down X.X% Knee the versus 'XX. or or X.X% In declined XXXX. U.S., performance in X.X% business third the
by driven strategic business X.X% introductions, XXXX. commercial trauma Hip added XX.X% or The sports versus and global acquisitions or declined U.S. And down Hips we this and contribution XXXX. X.X% or from 'XX. X.X% increased new category specialization, in versus portfolio versus the to down X.X% the XX extremity X.X% Our product declined continuing
declined category pressure declined business X% spine good to the when due increase to down and while market dental posted X.X% benefit dental execution recovery, The the compared from and COVID to and growth quarter. spine quarter Our strong continued XXXX in business XXXX, in versus throughout were and XXXX, the
demand Inside category Hip saw of this Other our the versus revenues increased and X.X% Knee, ongoing as our grew ROSA or we applications. for Finally, from as Partial down category, well Knee XXXX. XX.X% launch ROSA
P&L. the to Moving
third of spin-off GAAP per $X.XX share a For reported driven our the in litigation, per we higher This to the related by earnings of earnings and of quarter goods spending of and R&D. XXXX. quarter, cost share $X.XX was GAAP decrease primarily diluted lower diluted than our
year. tandem share versus $X.XX slightly down. results compared a On year, below even in per lower with our share gross In diluted tax was count. reductions with SG&A, expectations to in mix. prior targeted count product year geographic just slightly of adjusted which a implemented prior Adjusted and higher of and were tandem addition, sales offset share though investments below higher a lower up prior basis, and favorable was to the helped volumes We were the XX.X in earnings was in an the less margin rate due the our R&D flat
across stepped increases spite prior efficiency and versus and $XXX Robotics, ramp sequentially areas growth like in And that, of expenses investment other operating R&D we those up quarter. adjusted [Indiscernible], with year in we Data line improvements continue in across down Informatics. areas second Our offsetting the In of SG&A. commercial of priority million with are to infrastructure were the and and
line margin line tax The operating adjusted quarter was rate in was in XX.X%, prior and quarter XX.X% with the for expectations. of Our year in the largely prior our quarter. with adjusted the
just and cash ending equivalents liquidity, flow balance cash million. cash cash of $XXX million to and $XXX Turning we cash of $XXX free totaled flows million, and operating over with had an
We the of of date. down debt $XXX another $XXX make balance for pay continue to and million sheet good totaling on deleveraging XXXX paydown million progress debt to
have to based outlook at expected. COVID the The XXXX reductions, X full-year our new VBP more impact. as the a fourth bigger impact leading staffing existing fourth levels now pressure X. BVP currently are to their and Bryan will write-downs is approach and a than updated implementation higher factors: seasonally we of that that procedures cautious pressure China customer continue factor We've expect is quarter; the inventory, X. about procedure know guidance. we across impact we originally it on while and continuing the the impact financial of project increased our taking saw on to the volumes patients the up acute we than assumed. dynamics have Moving on improve more and of quarter inventory quarter, previously assuming And through in and a the price that September deferring timing mentioned, and the which into will fourth
impact result, to you VBP QX our implementation of results. the current for about fluid a But our will headwind is basis As VBP of and to update XXX we the unfolds. points situation consolidated continue remains as projections
full XX.X% to for of the year. a impact now versus XXXX FX tailwind an to XXX revenue we growth with expect For basis points the year, of XX.X% about reported be
to full-year. revenue response as adjusted While reducing XX.X% projections we XX% for our taking to margin outlook, lower our are a steps fourth quarter the spending the to to operating we're in reduce further be
full-year per in is of range the $X.XX now updated adjusted $X.XX. guidance Our to diluted share earnings
Our to the QX implies implementation. and XX% billion. and be And we a to VBP [Indiscernible] currency adjusted projection earnings share guidance between project to $X.XX. adjusted uncertainty outcomes unchanged for $X.XX finally, potential tax XXXX to surges, of that our will XX.X%. $X.X between in QX of guidance wider And to $XXX updated in free rate million +X.X% XXXX. QX full-year our account QX cash estimates This remain revenue pressure, constant is versus around per range range growth -X.X% kept at We COVID be the customer range flow
we as move related including into to do COVID pandemic that recovery XXXX. note, the believe mute shortages staffing pressure, continue a will As we
revenues transformation impact is and to Additionally, fundamentals strong this, environment efforts our Bryan. move continue VBP felt about joint successfully to challenges, to will call In to as business by mentioned impact will accelerating basis With control. we can I remain respond earlier, help headwinds. consolidated we presents execute the in efficiency summary, as be these we underlying what as against over segments XXX forward. margins XXXX back our macro expected [Indiscernible] are reduce large will we and the points. That to offset gross but we turn To that,